目的    探究依达拉奉对LPS激活的小胶质细胞Sirt3和MAPKs通路相关蛋白的作用及其调控机制。  方法    采用Western blot和免疫荧光双标染色检测LPS激活的BV2小胶质细胞中Sirt3和MAPKs通路相关蛋白ERK1/2、P38、JNK及p-ERK1/2、p-P38和p-JNK的表达;检测ERK1/2通路抑制剂处理后p-ERK1/2和Sirt3的表达。  结果    LPS激活的BV细胞中Sirt3、p-ERK1/2、p-P38和p-JNK表达显著增高,依达拉奉能促进Sirt3和p-ERK1/2过表达,并降低p-P38和p-JNK表达;ERK1/2抑制后p-ERK1/2和Sirt3的蛋白表达降低。依达拉奉可促进激活的BV2细胞中Sirt3和p-ERK1/2过表达,并下调过表达的p-P38和p-JNK。  结论    依达拉奉可调节BV2细胞中MAPKs信号通路并促进Sirt3生成,可能经ERK/Sirt3通路发挥抗炎作用。
						
						
						
						
						
							
Abstract
						
						
							Objective   To investigate the effect of edaravone on Sirt3 and MAPKs pathway-related proteins in LPS-activated microglia and its regulatory mechanism. Methods  Western Blot and immunofluorescence were used to detect the effect of edaravone on the protein expression of Sirt3 and MAPKs pathway-related proteins ERK1/2, P38, JNK as well as their phosphorylated forms p-ERK1/2, p-P38 and p-JNK in the activated BV2 cells. Western Blot techniques were applied to detect the effects of ERK1/2 pathway inhibitor on the expressions of p-ERK1/2 and Sirt3.   Results   The expressions of Sirt3, p-ERK1/2, p-P38 and p-JNK in microglia were significantly increased after BV2 cells activation. Edaravone promoted the expression of Sirt3 and p-ERK1/2 and downregulated the expression of p-JNK and p-P38. The protein expression of Sirt3 and p-ERK1/2 decreased after co-treatment with edaravone and ERK1/2 inhibitor. Edaravone promoted the overexpression of Sirt3 and p-ERK1/2 and downregulated the expression of p-JNK and p-P38. Conclusions    Edaravone can regulate MAPKs signaling pathway and promote Sirt3 production in BV2 cells, possibly regulates neuroinflammatory responses via ERK/Sirt3 signaling pathway.
						
						
					
					
					
					
					
					
					
						
关键词
					
					
						
							依达拉奉;   /  
						
							   /  
						
							Sirt3;   /  
						
							   /  
						
							小胶质细胞;   /  
						
							   /  
						
							MAPKs信号通路    
						
					
					
					
					
					
						
Key words
					
					
						
							Edaravone;   /  
						
							   /  
						
							Sirt3;   /  
						
							   /  
						
							Microglia;   /  
						
							   /  
						
							MAPKs signaling pathway    
						
					
					
					
					 
					
					
					
					
					
					
					
					
						
						
						
							
								
									
{{custom_sec.title}}
								
								
									
{{custom_sec.title}}
								
								
								
								{{custom_sec.content}}
							
						 
						
						
						
						
						
						
						
							
参考文献
						
						
							[1]  Spiteri AG, Wishart CL, Pamphlett R, et al. Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function[J]. Acta Neuropathol, 2022, 143(2): 179-224. DOI: 10.1007/s00401-021-02384-2.
[2] Wolf SA, Boddeke HW, Kettenmann H. Microglia in physiology and disease[J]. Annu Rev Physiol, 2017, 79: 619-643. DOI: 10.1146/ annurev-physiol-022516-034406.
[3] Yuan Y, Zha H, Rangarajan P, et al. Anti-inflammatory effects of edaravone and scutellarin in activated microglia in experimentally induced ischemia injury in rats and in BV2 microglia[J]. BMC Neurosci, 2014, 15: 125. DOI: 10.1186/s12868-014-0125-3.
[4] Chen HL, Jia WJ, Li HE, et al. Scutellarin exerts anti-inflammatory effects in activated microglia/brain macrophage in cerebral ischemia and in activated BV2 microglia through regulation of MAPKs signaling pathway[J]. Neuromolecular Med, 2020, 22(2): 264-277. DOI: 10.1007/s12017-019-08582-2.
[5] Sun J, Pu C, Yang E, et al. Macrophage/Microglia Sirt3 contributes to the anti-inflammatory effects of resveratrol against experimental intracerebral hemorrhage in mice[J]. Cell Mol Neurobiol, 2023, 43(6): 2871-2882. DOI: 10.1007/s10571-023-01325-9.
[6]  虞舒蓓, 林淑. 依达拉奉对脂多糖激活的BV2小胶质细胞中促炎细胞因子的影响[J]. 中国临床药理学杂志, 2019, 35(12): 1244-1246. DOI: 10.13699/j.cnki.1001-6821.2019.12.006.
[7] Yuan Y, Wu C, Ling EA. Heterogeneity of microglia phenotypes: developmental, functional and some therapeutic considerations[J]. Curr Pharm Des, 2019, 25(21): 2375-2393. DOI: 10.2174/138161282566619 0722114248.
[8] Yang L, Zhou R, Tong Y, et al. Neuroprotection by dihydrotestosterone in LPS-induced neuroinflammation[J]. Neurobiol Dis, 2020, 140: 104814. DOI: 10.1016/j.nbd.2020.104814.
[9] Plastira I, Bernhart E, Joshi L, et al. MAPK signaling determines lysophosphatidic acid (LPA)-induced inflammation in microglia[J]. J Neuroinflammation, 2020, 17(1): 127. DOI: 10.1186/s12974-020-01809-1.
[10]Meng W, Wang X, Lu L, et al. Effects of edaravone on cerebral ischemia-reperfusion in mice through the TLR4/NF-κB/TNF-α pathway[J]. Panminerva Med, 2021, 63(3): 383-384. DOI: 10.23736/S0031-0808.19.03693-0.
[11] Liu SJ, Liu XY, Li JH, et al. Gastrodin attenuates microglia activation through renin-angiotensin system and Sirtuin3 pathway[J]. Neurochem Int, 2018, 120: 49-63. DOI: 10.1016/j.neuint.2018.07.012.
[12] Yin J, Han P, Tang Z, et al. Sirtuin 3 mediates neuroprotection of ketones against ischemic stroke[J]. J Cereb Blood Flow Metab, 2015, 35(11): 1783-1789. DOI: 10.1038/jcbfm.2015.123.
[13] Ding M, Tolbert E, Birkenbach M, et al. Treprostinil reduces mitochondrial injury during rat renal ischemia-reperfusion injury[J]. Biomed Pharmacother, 2021, 141: 111912. DOI: 10.1016/j.biopha.2021.111912.
[14] Li N, Li X, Zheng K, et al. Inhibition of Sirtuin 3 prevents titanium particle-induced bone resorption and osteoclastsogenesis via suppressing ERK and JNK signaling[J]. Int J Biol Sci, 2021, 17(5): 1382-1394. DOI: 10.7150 /ijbs.53992.
						
						
						
						
						
						
						
						
						
						
						
						
							
								
基金
							
							
								国家自然科学基金(81960223);云南省科技厅昆明医科大学联合专项(202301AY070001-163);云南省大学生创新性实验计划项目;昆明医科大学大学生创新性实验计划项目(2022JXD301)